SCHEMBL541922

SCHEMBL541922

C1=NC(c2ccccc2)(c2ccccc2)N=N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28813222 0.79 LMNA (0.32)
SCHEMBL28227629 0.76
SCHEMBL10928766 0.73 OPRM1 (0.36)
SCHEMBL10650069 0.73 PNMT (0.34)
SCHEMBL11222671 0.73 MEN1 (0.30)
SCHEMBL26908144 0.69 OPRM1 (0.33)
SCHEMBL5274311 0.69 OPRM1 (0.33)
Bromide SCHEMBL29801969 0.67 OPRM1 (0.32)
Bromide SCHEMBL28070425 0.67 OPRM1 (0.32)
SCHEMBL28215026 0.66 TDP1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3538898-A1 PROTHROMBIN TIME REAGENT COMPRISING AN IRON CHELATOR Siemens Healthcare Diagnostics Products GmbH (DE) 2019-09-18 EP claimed
CN-103468246-A Organic luminescent material containing 1,2,4-tolyltriazole as well as preparation method and electroluminescent appliance of organic luminescent material containing 1,2,4-tolyltriazole JILIN OPTICAL & ELECTRONIC MATERIALS CO LTD 2013-12-25 CN claimed
US-20120294826-A1 METHODS, KITS AND COMPOSITIONS FOR AMELIORATING ADVERSE EFFECTS ASSOCIATED WITH TRANSFUSION OF AGED RED BLOOD CELLS NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2012-11-22 US claimed
EP-2442641-A1 METHODS FOR AMELIORATING ADVERSE EFFECTS ASSOCIATED WITH TRANSFUSION OF AGED RED BLOOD CELLS The Trustees of Columbia University in the City of New York (US) 2012-04-25 EP claimed
WO-2010147621-A1 METHODS FOR AMELIORATING ADVERSE EFFECTS ASSOCIATED WITH TRANSFUSION OF AGED RED BLOOD CELLS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2010-12-23 WO claimed
EP-3765569-A1 LOW COMPRESSION SET SILICON RUBBER COMPOSITION Momentive Performance Materials GmbH (DE) 2021-01-20 EP disclosed
WO-2019175092-A1 LOW COMPRESSION SET SILICON RUBBER COMPOSITION MOMENTIVE PERFORMANCE MATERIALS GMBH (DE) 2019-09-19 WO disclosed
CN-103468246-B A kind of luminous organic material, its preparation method and electroluminescent device thereof containing 1,2,4-triazole Jilin Optical and Electronic Materials Co., Ltd. (CN) 2016-05-11 CN disclosed
EP-2707432-A1 METHOD OF PROTECTING TRANSPARENT NONMETALLIC ELECTROCONDUCTIVE PARTS Dow Corning Toray Co., Ltd. (JP) 2014-03-19 EP disclosed
CN-103468246-A Organic luminescent material containing 1,2,4-tolyltriazole as well as preparation method and electroluminescent appliance of organic luminescent material containing 1,2,4-tolyltriazole JILIN OPTICAL & ELECTRONIC MATERIALS CO LTD 2013-12-25 CN disclosed
CN-101448397-B Selective benzylamine derivatives and their use as cholesteryl ester transfer protein inhibitors REDDYS LAB LTD DR 2013-04-24 CN disclosed
WO-2012157732-A1 METHOD OF PROTECTING TRANSPARENT NONMETALLIC ELECTROCONDUCTIVE PARTS DOW CORNING TORAY CO., LTD. (JP) 2012-11-22 WO disclosed
CN-101500561-A Use of iron chelators for treating endocrine dysfunction NOVARTIS AG (CH) 2009-08-05 CN disclosed
WO-2008150441-A1 IMAGEABLE ELEMENTS AND METHODS OF USE IN NEGATIVE WORKING LITHOGRAPHIC PRINTING PLATES EASTMAN KODAK COMPANY (US) 2008-12-11 WO disclosed
CN-1889952-A (a) Combination of N- { 5- [ 4- (4-methyl- (piperazin-1-yl) -methyl) -benzamido ] -2-methylphenyl } -4- (3-pyridyl) -2-pyrimidin-amine and (b) at least one hypusination inhibitor and its use NOVARTIS AG (CH) 2007-01-03 CN disclosed
EP-1385047-A1 Silver (carboxylate-N-alkyl thiolate) particles for photothermographic or thermographic imaging EASTMAN KODAK COMPANY (US) 2004-01-28 EP disclosed
EP-1385048-A1 Silver-(carboxylate-azine toner) particles for photothermographic and thermographic imaging EASTMAN KODAK COMPANY (US) 2004-01-28 EP disclosed
EP-1071670-A1 NOVEL DIPHENYL-SUBSTITUTED 5-RING-HETEROCYCLES, METHOD FOR PRODUCING THEM AND THEIR USE AS MEDICAMENTS BOEHRINGER INGELHEIM KG (DE) 2001-01-31 EP disclosed
WO-1999054314-A1 NOVEL DIPHENYL-SUBSTITUTED 5-RING-HETEROCYCLES, METHOD FOR PRODUCING THEM AND THEIR USE AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-10-28 WO disclosed
EP-0608132-A1 Coating varnish composition and antifouling coating composition HITACHI CHEMICAL CO., LTD. (JP) 1994-07-27 EP disclosed